Published in J Clin Psychiatry on April 01, 2005
Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull (2008) 1.77
A review of postpartum psychosis. J Womens Health (Larchmt) (2006) 1.40
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39
Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22
Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull (2008) 1.06
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03
Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol (2013) 0.95
Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry (2012) 0.92
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry (2016) 0.90
A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS One (2014) 0.90
Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open (2013) 0.88
Teratogenicity with olanzapine. Indian J Psychol Med (2014) 0.86
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol (2015) 0.86
Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl) (2013) 0.84
Mood stabilizers in pregnancy and lactation. Indian J Psychiatry (2015) 0.83
Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium. Can Fam Physician (2014) 0.81
Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am Health Drug Benefits (2014) 0.81
Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report. Ther Adv Psychopharmacol (2012) 0.80
Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biol Psychiatry (2012) 0.80
Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf (2014) 0.78
Effect of atypical antipsychotics on fetal growth: is the placenta involved? J Pregnancy (2012) 0.77
Perinatal Generalized Anxiety Disorder: Assessment and Treatment. J Womens Health (Larchmt) (2015) 0.76
Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. Pharmacogenomics J (2016) 0.75
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf (2014) 0.75
Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One (2015) 0.75
Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis. PLoS One (2015) 0.75
Ziprasidone in the treatment of mania in bipolar disorder. Neuropsychiatr Dis Treat (2007) 0.75
Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. J Am Assoc Nurse Pract (2015) 0.75
Atypical antipsychotic use during the first trimester of pregnancy may not increase major malformations. Evid Based Ment Health (2005) 0.75
Bipolar disorder in women. Indian J Psychiatry (2015) 0.75
Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure. J Pediatr (2016) 0.75
Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness? Psychopharmacology (Berl) (2014) 0.75
Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database. Drug Saf (2017) 0.75
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry (2006) 4.18
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
Pregnancy outcome after in utero exposure to local anesthetics as part of dental treatment: A prospective comparative cohort study. J Am Dent Assoc (2015) 3.35
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf (2005) 2.21
Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry (2003) 2.11
Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am J Psychiatry (2013) 2.06
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res (2006) 1.81
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr (2012) 1.73
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry (2007) 1.72
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res (2010) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia (2002) 1.62
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology (2007) 1.56
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol (2002) 1.55
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry (2002) 1.51
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry (2003) 1.49
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry (2014) 1.45
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44
Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43
Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43
Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42
Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42
Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ (2005) 1.41
Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41
Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol (2009) 1.41
Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf (2003) 1.40
Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40
Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39
Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39
Electric shock during pregnancy. Can Fam Physician (2003) 1.39
"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39
Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35
Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol (2005) 1.35
Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol (2006) 1.34